Onconova Therapeutics (NASDAQ:ONTX) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.21) by 23.81 percent. This is a 18.18 percent decrease over losses of $(0.22) per
Onconova Therapeutics (NASDAQ:ONTX) reported quarterly earnings of $0.26 per share. This is a 218.18 percent increase over losses of $(0.22) per share from the same period last year.